Staging esophageal cancer

Cancer Imaging

Volumn 8, Issue SPEC. ISS. A, 2008, Pages

  Quint, Leslie Eisenbud ^a   Bogot, Naama R ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Computed tomography; Esophageal cancer; FDG PET scanning; Neoplasm staging

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; BONE METASTASIS; BRONCHOSCOPY; CANCER INVASION; CANCER STAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; RELIABILITY; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55149101793     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2008.9007     Document Type: Article

References (39)

1. Bogot N, Quint L. CT in esophageal cancer. In: Rankin SC, editor. Carcinoma of the esophagus. Cambridge: Cambridge University Press; 2008, p. 62-84.
2. AJCC cancer staging handbook. New York: Springer-Verlag; 2002.
3. Patti MG, Gantert W, Way LW. Surgery of the esophagus. Anatomy and physiology. Surg Clin North Am 1997; 77: 959-70.
4. Riquet M, Saab M, Le Pimpec Barthes F, Hidden G. Lymphatic drainage of the esophagus in the adult. Surg Radiol Anat 1993; 15: 209-11.
5. SEER NCI. Cancer of the esophagus. http://seer.cancer.gov/statfacts/html/ esoph.html, 2008.
6. Quint LE, Hepburn LM, Francis IR, Whyte RI, Orringer MB. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 1995; 76: 1120-5.
7. Cen P, Hofstetter WL, Lee JH, et al. Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma. Cancer 2008; 112: 503-10.
8. Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 2000; 10: 471-85.
9. Panebianco V, Grazhdani H, Iafrate F, et al. 3D CT protocol in the assessment of the esophageal neoplastic lesions: can it improve TNM staging? Eur Radiol 2006; 16: 414-421.
10. Wayman J, Chakraverty S, Griffin SM, Doyle GJ, Keir MJ, Simpson W. Evaluation of local invasion by oesophageal carcinoma - a prospective study of prone computed tomography scanning. Postgrad Med J 2001; 77: 181-4.
11. Picus D, Balfe DM, Koehler RE, Roper CL, Owen JW. Computed tomography in the staging of esophageal carcinoma. Radiology 1983; 146: 433-8.
12. Takashima S, Takeuchi N, Shiozaki H, et al. Carcinoma of the esophagus: CT vs MR imaging in determining resectability. AJR Am J Roentgenol 1991; 156: 297-302.
13. Lehr L, Rupp N, Siewert JR. Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging. Surgery 1988; 103: 344-50.
14. Rankin S. The role of computerized tomography in the staging of oesophageal cancer. Clin Radiol 1990; 42: 152-3.
15. Kumbasar B. Carcinoma of esophagus: radiologic diagnosis and staging. Eur J Radiol 2002; 42: 170-80.
16. Cerfolio RJ, Bryant AS. Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg 2006; 82: 391-4 (discussion 394-5).
17. van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 2008; 98: 547-57.
18. Balfe DM, Mauro MA, Koehler RE, et al. Gastrohepatic ligament: normal and pathologic CT anatomy. Radiology 1984; 150: 485-90.
19. Schroder W, Baldus SE, Monig SP, Beckurts TK, Dienes HP, Holscher AH. Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis. World J Surg 2002; 26: 584-7.
20. Wu LF, Wang BZ, Feng JL, et al. Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI. World J Gastroenterol 2003; 9: 219-24.
21. Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection - prospective study. Radiology 2003; 227: 764-70.
22. Kato H, Miyazaki T, Nakajima M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 2005; 103: 148-56.
23. van Westreenen HL, Westerterp M, Bossuyt PM, et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 2004; 22: 3805-12.
24. Bar-Shalom R, Guralnik L, Tsalic M, et al. The additional value of PET/CT over PET in FDG imaging of oesophageal cancer. Eur J Nucl Med Mol Imaging 2005; 32: 918-24.
25. Yuan S, Yu Y, Chao KSC, et al. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med 2006; 47: 1255-9.
26. Gollub MJ, Lefkowitz R, Moskowitz CS, Ilson D, Kelsen D, Felderman H. Pelvic CT in patients with esophageal cancer. AJR Am J Roentgenol 2005; 184: 487-90.
27. Meyers BF, Downey RJ, Decker PA, et al. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 2007; 133: 738-45.
28. Blackstock AW, Farmer MR, Lovato J, et al. A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 2006; 64: 455-60.
29. Luketich JD, Friedman DM, Weigel TL, et al. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 1999; 68: 1133-6.
30. Kato H, Miyazaki T, Nakajima M, et al. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Anticancer Res 2005; 25: 4439-44.
31. van Westreenen HL, Heeren PA, van Dullemen HM, et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg 2005; 9: 54-61.
32. Duong CP, Demitriou H, Weih L, et al. Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer. Eur J Nucl Med Mol Imaging 2006; 33: 759-69.
33. Thompson WM. Esophageal carcinoma. Abdom Imaging 1997; 22: 138-42.
34. Riddell AM, Allum WH, Thompson JN, Wotherspoon AC, Richardson C, Brown G. The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathological correlation. Eur Radiol 2007; 17: 391-9.
35. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002; 224: 748-56.
36. Buenaventura P, Luketich JD. Surgical staging of esophageal cancer. Chest Surg Clin N Am 2000; 10: 487-97.
37. de Graaf GW, Ayantunde AA, Parsons SL, Duffy JP, Welch NT. The role of staging laparoscopy in oesophagogastric cancers. Eur J Surg Oncol 2007; 33: 988-92.
38. NCCN clinical practice guidelines in oncology. http://www.nccn.org, 2008.
39. Wallace MB, Nietert PJ, Earle C, et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg 2002; 74: 1026-32.